Skip to main content
logo
Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.340
0.00 (0.00%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Calidi Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
392254100282
Market Cap Growth
-59.98%-61.46%-58.52%-46.69%-64.38%-
Enterprise Value
123053--
Last Close Price
1.3418.72220.812899.3219527.1818835.95

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----2232.17628.13
PB Ratio
0.892.2811.29-6.50-2.46-12.47
P/TBV Ratio
1.112.2814.48---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.620.683.58-0.88-0.15-0.23
Net Debt / Equity Ratio
-0.68-0.81-1.30-0.64-0.14-0.13
Net Debt / EBITDA Ratio
0.130.160.13-0.18-0.25-0.32
Net Debt / FCF Ratio
-0.140.13-0.19-0.41-0.38
Asset Turnover
----0.020.17
Quick Ratio
1.261.421.010.320.010.08
Current Ratio
1.681.591.080.420.020.11
Return on Equity (ROE)
-672.22%-700.65%----
Return on Assets (ROA)
-134.78%-109.81%-112.47%-287.25%-482.80%-229.02%
Return on Capital Employed (ROCE)
-450.00%-411.20%-464.70%13611.30%57.30%42.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-674.89%-232.50%-99.69%-54.56%-25.31%-3.88%
FCF Yield
-529.33%-250.10%-88.73%-51.48%-13.58%-2.83%
Buyback Yield / Dilution
-537.31%-544.97%----
SEC Filings: 10-K · 10-Q